CN Patent
CN103656657A — 特立氟胺药物组合物及制备方法
Assigned to BEIJING KEYUAN CHUANGXIN TECHNOLOGY Co Ltd · Expires 2014-03-26 · 12y expired
What this patent protects
本发明公开了本发明公开了一种特立氟胺药物组合物,其特征是该药物组合物由下列成分及百分比组成:5%-20%特立氟胺、30%-50%无水乳糖、20%-40%微晶纤维素、5%-10%交联聚乙烯吡咯烷酮、1%-10%泊洛沙姆、1%-2%微粉硅胶组成,该特立氟胺药物组合物稳定性好,对提高产品收率,降低成本,实现产业化,更好的应用于临床,具有更明显的优势。
USPTO Abstract
本发明公开了本发明公开了一种特立氟胺药物组合物,其特征是该药物组合物由下列成分及百分比组成:5%-20%特立氟胺、30%-50%无水乳糖、20%-40%微晶纤维素、5%-10%交联聚乙烯吡咯烷酮、1%-10%泊洛沙姆、1%-2%微粉硅胶组成,该特立氟胺药物组合物稳定性好,对提高产品收率,降低成本,实现产业化,更好的应用于临床,具有更明显的优势。
Drugs covered by this patent
- Aubagio (TERIFLUNOMIDE) · Sanofi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.